Olav Dahl

SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas

Adam J. Bass, Hideo Watanabe, Craig H. Mermel et al. · Nature Genetics · 2009 · 944 citations · Full text

Tumor Biology, Oncogenic Agent, Medicine +9

Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma

Jens Overgaard, Søren M. Bentzen, Jens Overgaard et al. · The Lancet · 1995 · 577 citations · Full text

Surgical Oncology, Hyperthermia, Metastatic Malignant Melanoma +7

Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of vater—results of a controlled, prospective, randomised multicentre study

K Bakkevold, B. Arnesjø, Olav Dahl et al. · European Journal of Cancer · 1993 · 339 citations

Surgical Oncology, Pancreatic Cancer, Gastrointestinal Oncology +7

Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome

Øystein Fluge, Olav Mella, Ove Bruland et al. · JCI Insight · 2016 · 201 citations · Full text

Metabolic Syndrome, Energy Metabolism, Amino Acid Pattern +14

Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. A Double-Blind and Placebo-Controlled Study

Øystein Fluge, Ove Bruland, Kristin Risa et al. · PLoS ONE · 2011 · 196 citations · Full text